-
Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: CheckMate 649 biomarker analyses
Study
EGAS50000000747
-
An Integrated Approach to Patient Stratification and Therapy Selection in Acute Myeloid Leukemia
Study
EGAS00001004655
-
Clinical relevance of TCGA subtypes for gastric cancer patients
Study
EGAS50000000779
-
Development of a fully human glioblastoma-in-brain-spheroid model for accelerated translational research
Study
EGAS50000000757
-
Djerroudi et al., E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular carcinoma
Study
EGAS50000000761
-
Aggressive PDACs show hypomethylation of repetitive elements and the execution of an intrinsic IFN program linked to a ductal cell-of-origin
Study
EGAS00001004660
-
A non-canonical lymphoblast in refractory childhood T-cell leukaemia
Study
EGAS50000000767
-
MIBC NAC2020 cohort RNA sequencing
Study
EGAS50000000741
-
Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer
Study
EGAS50000000775
-
Pyjacker identifies enhancer hijacking events in acute myeloid leukemia including MNX1 activation via deletion 7q
Study
EGAS50000000743